Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 648294, 6 pages
http://dx.doi.org/10.1155/2014/648294
Research Article

Rapid Detection of Rifampicin and Isoniazid Resistant Mycobacterium tuberculosis Using Genotype MTBDRplus Assay in Nepal

1Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal
2German Nepal Tuberculosis Project (GENETUP), Kathmandu, Nepal

Received 8 April 2014; Accepted 2 August 2014; Published 29 October 2014

Academic Editor: Christopher M. Parry

Copyright © 2014 Bijay Kumar Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Tuberculosis Report, World Health Organization, Geneva, Switzerland, 2012.
  2. National Tuberculosis Centre, “National Tuberculosis Programme of Nepal,” Annual Report 2011/12, Ministry of Health and Population, Department of Health Service, 2012. View at Google Scholar
  3. G. B. Migliori, R. Loddenkemper, F. Blasi, and M. C. Raviglione, “125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?” European Respiratory Journal, vol. 29, no. 3, pp. 423–427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Raviglione and I. M. Smith, “XDR tuberculosis: implications for global public health,” New England Journal of Medicine, vol. 356, no. 7, pp. 656–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Wright, M. Zignol, A. Van Deun et al., “Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance,” The Lancet, vol. 373, no. 9678, pp. 1861–1873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Gillespie, “Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 2, pp. 267–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Hillemann, M. Weizenegger, T. Kubica, E. Richter, and S. Niemann, “Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates,” Journal of Clinical Microbiology, vol. 43, no. 8, pp. 3699–3703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Hillemann, S. Rüsch-Gerdes, and E. Richter, “Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens,” Journal of Clinical Microbiology, vol. 45, no. 8, pp. 2635–2640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. K. Varma, D. Wiriyakitjar, S. Nateniyom et al., “Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004-2005,” Bulletin of the World Health Organization, vol. 85, no. 8, pp. 586–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. C. Victor, R. Warren, J. L. Butt et al., “Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis,” Journal of Medical Microbiology, vol. 46, no. 10, pp. 847–857, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. World Health Organization, Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis (MDR-TB): Policy Statement, World Health Organization, Geneva, Switzerland, 2008.
  12. D. I. Ling, A. A. Zwerling, and M. Pai, “GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis,” European Respiratory Journal, vol. 32, no. 5, pp. 1165–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Bwanga, S. Hoffner, M. Haile, and M. L. Joloba, “Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis,” BMC Infectious Diseases, vol. 9, article 67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Dorman, V. N. Chihot, J. J. Lewis et al., “Genotype MTBDRplus for direct detection of mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa,” Journal of Clinical Microbiology, vol. 50, no. 4, pp. 1189–1194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. E. Akpaka, S. Baboolal, D. Clarke, L. Francis, and N. Rastogi, “Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean,” Journal of Clinical Microbiology, vol. 46, no. 10, pp. 3426–3428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Dahal, N. Adhikari, Y. Shah, R. Simkhada, B. Maharjan, and B. Shrestha, “Evaluation of Genotype MTBDRplus Assay for identifying Multidrug Resistant Mycobacterium tuberculosis isolates in Nepal,” Janaki Medical College Journal of Medical Science, vol. 1, no. 1, pp. 30–37, 2013. View at Google Scholar
  17. X. Ma, H. Wang, Y. Deng et al., “rpoB gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3409–3412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Traore, K. Fissette, I. Bastian, M. Devleeschouwer, and F. Portaels, “Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance,” International Journal of Tuberculosis and Lung Disease, vol. 4, no. 5, pp. 481–484, 2000. View at Google Scholar · View at Scopus
  19. A. Poudel, C. Nakajima, Y. Fukushima et al., “Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 6, pp. 2831–2836, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. N. T. Huyen, E. W. Tiemersma, N. T. N. Lan et al., “Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam,” BMC Infectious Diseases, vol. 10, article 149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Rienthong, S. Rienthong, C. Boonin, S. Woraswad, and Y. Kasetjaroen, “Rapid detection for early appearance of Rifampin and Isoniazid resistance in Mycobacterium tuberculosis,” Siriraj Medical Journal, vol. 61, no. 1, pp. 49–55, 2009. View at Google Scholar
  22. R. N. Yadav, B. K. Singh, S. K. Sharma et al., “Comparative evaluation of genotype MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India,” PLoS ONE, vol. 8, no. 9, Article ID e72036, 2013. View at Google Scholar
  23. J. Yue, W. Shi, J. Xie, Y. Li, E. Zeng, and H. Wang, “Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China,” Journal of Clinical Microbiology, vol. 41, no. 5, pp. 2209–2212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Raveendran, C. Wattal, J. K. Oberoi, N. Goel, S. Datta, and K. J. Prasad, “Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India,” Indian Journal of Medical Microbiology, vol. 30, no. 1, pp. 58–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. F. A. Drobniewski and S. M. Wilson, “The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis—a molecular story,” Journal of Medical Microbiology, vol. 47, no. 3, pp. 189–196, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. S. B. Marahatta, S. Gautam, S. Dhital et al., “KatG (SER 315 THR) gene mutation in isoniazid resistant Mycobacterium tuberculosis,” Kathmandu University Medical Journal, vol. 9, no. 33, pp. 19–23, 2011. View at Google Scholar · View at Scopus
  27. P. Miotto, F. Piana, D. M. Cirillo, and G. B. Migliori, “Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 46, no. 1, pp. 393–394, 2008. View at Publisher · View at Google Scholar · View at Scopus